The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Teva Pharmaceutical Industries Ltd
SWB:TEV
|
IL |
|
Percheron Therapeutics Ltd
ASX:PER
|
AU |
|
L
|
Laramide Resources Ltd
F:L4R
|
CA |
|
WhiteHorse Finance Inc
NASDAQ:WHF
|
US |
|
R
|
Relx PLC
F:RDED
|
UK |
|
Astra Agro Lestari Tbk PT
IDX:AALI
|
ID |
|
Physicians Realty Trust
NYSE:DOC
|
US |
|
R
|
Relx PLC
NYSE:RELX
|
UK |
|
Cuscal Ltd
F:Y49
|
AU |
|
C
|
Charles Schwab Corp
DUS:SWG
|
US |
|
E
|
Endesa SA
XMUN:ENA
|
ES |
|
N
|
NovaBay Pharmaceuticals Inc
AMEX:SDEV
|
US |
|
UniCredit SpA
F:CRIP
|
IT |
|
Klepierre SA
PAR:LI
|
FR |
|
Canyon Resources Ltd
ASX:CAY
|
AU |
|
Genix Pharmaceuticals Corp
XTSX:GENX
|
CA |
|
M
|
Mitsubishi Estate Co Ltd
DUS:MES
|
JP |
|
Nexgen Energy Ltd
LSE:0V9D
|
CA |
|
E
|
Endesa SA
DUS:ENA
|
ES |
|
A
|
Alliant Energy Corp
F:AY1
|
US |
|
A
|
Apple Inc
XHAM:APC
|
US |
|
Max Resource Corp
OTC:MXROF
|
CA |
|
Sword Group SE
PAR:SWP
|
LU |
|
P
|
PLDT Inc
OTC:PHTCF
|
PH |
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
TEV does not have any price targets made by Wall Street professionals.
Over the last 13 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 8 years is 3%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been -1%. The projected CAGR for the next 8 years is 4%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 8 years is 7%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -3%. The projected CAGR for the next 3 years is 61%.
Over the last 13 years, the compound annual growth rate for Net Income has been -3%. The projected CAGR for the next 8 years is 20%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more